PLATA OSCURO MB METALICO

MM-23552D-35 KK VERDE MB 35

STAN-TONE MB-36084 GNTN BL 5010 V2

Microsoft PowerPoint - AVNT Q4 2022 Earnings Presentation AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 2 R E S U L T S A N D 2 0 2 3 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A RY 1 5 , 2 0 2 3 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. GUIDANCE DEBT / LEVERAGE REDUCTION • Completed sale of Distribution and paid down $750M of debt in November • Strong free cash flow in fourth quarter reduced leverage and enabled paydown of additional $200M of debt • Fixed/Floating Debt Ratio 63/37 • Proven track record of deleveraging following acquisitions through consistent free cash flow generation $725 $725 $725 $575 $500 $400 $600 $525 $425 $650 $650 $650 $600 $2.40B $2.20B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes After Distribution Divestiture Year-End Year-End Leverage 3.8x 3.1x 2.9x 2023 Notes After Avient Protective Materials Acquisition $3.15B 2022 TRANSFORMATIONAL PORTFOLIO ENHANCEMENTS 5 EBITDA margins expanded from 12% to 16% Diversified end markets with reduced exposure to more cyclical industries Dyneema® Acquisition $1.48B acquisition strengthens composites platform Significantly improved EBITDA margins $950M divestiture results in 100% specialty sales Strong exit multiple of 10x TTM EBITDA despite market volatility Distribution Divestiture Improved Portfolio GROWING COMPOSITES PLATFORM CONTRIBUTIONS TO SEM SEGMENT 6 Note: 2022 is pro forma for Avient Protective Materials 2016 Sales 2022 Sales Advanced Composites 51% $560M $1,300M Advanced Composites COMPOSITES PORTFOLIO D Y N E E M A ® E X P A N D S O U R E N G I N E E R E D F I B E R S A N D T A P E S T E C H N O L O G Y LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers 7 ADVANCED COMPOSITES PERFORMANCE 8 (1) Pro forma for the acquisition of Avient Protective Materials $51 $84 $212 $668 $4 $10 $41 $169 (1) (1) PORTFOLIO EVOLUTION AND EPS EXPANSION 9 Adj. Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 29 EV / 2023E EBITDA Historic Multiple 6.5 8.3 10.0 15.6 13.9 13.7 12.8 9.5 18.0 17.5 12.3 10.2 9.7 8.8 8.4 5.9 (2 01 1) (2 01 8) SEGMENT DATA U.S. & Canada 40% 37% 18% Latin America 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Building and END MARKET REVENUE (1) Total company adjusted EBITDA of $592M includes corporate costs $2,355M $402M $1,300M $272M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $592M$3,653M 31 C O L O R , A D D I T I V E S & I N K S 2022 REVENUE | $2 .4 B ILL ION US & Canada 34% 38% Latin America END MARKET REGION 32 34% 21% Building & 1% Energy 2% S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 2022 PRO FORMA REVENUE | $1 .3 B ILL ION END MARKET US & Canada 52% 35% REGION 33 19% 8%Industrial 16% Building & 32% 27% 14% Building & 3% 1% Defense 1% (18% of sales) 2022 PROFORMA AVIENT REGIONAL SALES BY END MARKET 27% 14% 17% Building & (37% of sales)Transportation 12% Building & US & Canada (40% of sales) 7% 56% 23% 7% Building & 1% LATAM (5% of sales) 3% 34 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

AVIENT CORPORATION P R O F O R M A F I N A N C I A L S F O R D Y N E E M A A C Q U I S I T I O N A N D D I S T R I B U T I O N A S D I S C O N T I N U E D O P E R A T I O N S (NYSE: AVNT) S E P T E M B E R 2 7 , 2 0 2 2 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.

U KAS MANAC〔M〔N丁 SYSTEMS 0005 、端；薰；; HCSGS 13485 2016 Olin ：氨 城心〔找n心亡〔 ．．八 护、产、八 j丹月六户 八八月户 八月月‘、 ）如》 称资熨面蔚若三 「｛羹 StS55G S GSlfS5SG56SGSGSGSGSGSG5G5 f5 嚷i羹羹巍熊燕鬓；；奎忿 rage I Oil;；燕七 :终 sds 0Gs、 山5互 0s's""“ 刀之： J"‘、 ,slttiGsti.' China has been assessed and certified as meeting the requirements of 麟 ISO 13485:2016 EN ISO 13485:2016 ’骥鑫馨瓤） For the foiowing actratEes Design and manufacture of medical grade thermoplastic elastomers for non-active medical devices and active medical devices 遴；舞蒸；撇蒸 (non-implantable) ：护、：：于b入沙黔娜；舞睡莎：器器舞蟒檬非拟拐称群亘爸竺舀‘。

Impuesto a las Ganancias: la condición de exenta, para las entidades enunciadas en los incisos b), d), e), f), g), m) y r) del Art. 20 de la ley, se acredita mediante el "Certificado de exención en el Impuesto a las Ganancias" - Resolución General 2681

Robert M. Kevin M.

Robert M. Kevin M.

Robert M. Robert M.